This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-342-3p | AACS | -0.2 | 3.0E-5 | 0.18 | 0.00035 | miRanda | -0.4 | 0.00057 | NA | |
2 | hsa-miR-188-5p | AAK1 | 0.48 | 7.0E-5 | -0.25 | 0.00754 | PITA | -0.28 | 0.00067 | NA | |
3 | hsa-miR-636 | AAK1 | 0.37 | 0.00023 | -0.25 | 0.00754 | PITA | -0.25 | 0.0157 | NA | |
4 | hsa-miR-342-3p | AAMP | -0.2 | 3.0E-5 | 0.12 | 0.01751 | PITA; miRanda; miRNATAP | -0.26 | 0.0309 | NA | |
5 | hsa-miR-139-5p | AASDHPPT | -0.96 | 0 | 0.3 | 0.00018 | miRanda | -0.11 | 0.04034 | NA | |
6 | hsa-miR-342-3p | AASDHPPT | -0.2 | 3.0E-5 | 0.3 | 0.00018 | miRanda | -0.47 | 0.01589 | NA | |
7 | hsa-miR-139-5p | ABCA13 | -0.96 | 0 | 0.16 | 0.01084 | miRanda | -0.11 | 0.00784 | NA | |
8 | hsa-miR-129-5p | ABCA5 | 0.13 | 0.23985 | -1.21 | 0 | mirMAP | -0.5 | 0.01622 | NA | |
9 | hsa-miR-342-3p | ABCB10 | -0.2 | 3.0E-5 | 0.08 | 0.04456 | miRanda | -0.27 | 0.00385 | NA | |
10 | hsa-miR-133b | ABCC1 | -0.56 | 0 | 0.49 | 1.0E-5 | miRNATAP | -0.21 | 0.04929 | NA | |
11 | hsa-miR-107 | ABCC12 | 0.02 | 0.45295 | 0.08 | 0.17235 | miRanda | -0.62 | 0.03045 | NA | |
12 | hsa-miR-1283 | ABHD13 | -0.15 | 0.08004 | -0.02 | 0.88905 | mirMAP | -0.42 | 0.00316 | NA | |
13 | hsa-miR-1253 | ABHD17B | 0 | 0.96973 | -0.31 | 0.00061 | MirTarget | -0.43 | 0.00235 | NA | |
14 | hsa-miR-139-5p | ABHD2 | -0.96 | 0 | 0.62 | 1.0E-5 | miRanda | -0.2 | 0.04461 | NA | |
15 | hsa-miR-518d-5p | ABHD2 | -0.17 | 0.02136 | 0.62 | 1.0E-5 | mirMAP | -0.55 | 0.0185 | NA | |
16 | hsa-miR-607 | ABI1 | -0.07 | 0.34593 | 0.02 | 0.83355 | mirMAP | -0.29 | 0.02294 | NA | |
17 | hsa-miR-342-3p | ABI2 | -0.2 | 3.0E-5 | 0.25 | 0.00518 | miRanda | -0.53 | 0.01527 | NA | |
18 | hsa-miR-1275 | ABL1 | 0.24 | 0.00451 | -0.24 | 0.00022 | MirTarget | -0.26 | 0.00295 | NA | |
19 | hsa-miR-621 | ABL2 | -0.26 | 0.00457 | 0.2 | 0.00058 | miRNATAP | -0.15 | 0.03366 | NA | |
20 | hsa-miR-129-5p | ABLIM1 | 0.13 | 0.23985 | -0.26 | 0.00378 | miRanda; mirMAP | -0.25 | 0.0103 | NA | |
21 | hsa-miR-556-5p | ABLIM1 | 0.21 | 0.0022 | -0.26 | 0.00378 | mirMAP | -0.32 | 0.03105 | NA | |
22 | hsa-miR-875-3p | ABLIM1 | 0.18 | 0.096 | -0.26 | 0.00378 | mirMAP | -0.2 | 0.0312 | NA | |
23 | hsa-miR-1283 | ACACA | -0.15 | 0.08004 | 0.51 | 0 | MirTarget; PITA; miRNATAP | -0.28 | 0.03408 | NA | |
24 | hsa-miR-139-5p | ACACA | -0.96 | 0 | 0.51 | 0 | miRanda | -0.24 | 0.00015 | NA | |
25 | hsa-miR-654-5p | ACACB | 0.2 | 0.03487 | -0.69 | 0 | MirTarget | -0.4 | 0.00304 | NA | |
26 | hsa-miR-133b | ACAD9 | -0.56 | 0 | 0.22 | 0.00043 | miRanda | -0.14 | 0.01482 | NA | |
27 | hsa-miR-1275 | ACADS | 0.24 | 0.00451 | -0.45 | 0 | MirTarget | -0.22 | 0.04518 | NA | |
28 | hsa-miR-342-3p | ACAN | -0.2 | 3.0E-5 | 0.26 | 0 | miRanda | -0.31 | 0.02467 | NA | |
29 | hsa-miR-133b | ACAT2 | -0.56 | 0 | -0.08 | 0.41551 | MirTarget; miRanda; miRNATAP | -0.18 | 0.04704 | NA | |
30 | hsa-miR-139-5p | ACD | -0.96 | 0 | 0.28 | 0 | miRanda | -0.11 | 0.00421 | NA | |
31 | hsa-miR-875-3p | ACER3 | 0.18 | 0.096 | -0.53 | 0 | MirTarget | -0.28 | 0.02029 | NA | |
32 | hsa-miR-139-5p | ACLY | -0.96 | 0 | 0.48 | 0 | miRanda | -0.16 | 0.02448 | NA | |
33 | hsa-miR-875-3p | ACO1 | 0.18 | 0.096 | -0.15 | 0.11163 | MirTarget | -0.24 | 0.01882 | NA | |
34 | hsa-miR-875-3p | ACOT11 | 0.18 | 0.096 | -0.25 | 0.00067 | mirMAP | -0.29 | 0.0001 | NA | |
35 | hsa-miR-636 | ACOX1 | 0.37 | 0.00023 | -0.69 | 0 | mirMAP | -0.38 | 0.00835 | NA | |
36 | hsa-miR-568 | ACP2 | 0.08 | 0.30754 | -0.11 | 0.04075 | miRNATAP | -0.17 | 0.0445 | NA | |
37 | hsa-miR-607 | ACSL4 | -0.07 | 0.34593 | 0.29 | 0.04133 | mirMAP; miRNATAP | -0.52 | 0.02099 | NA | |
38 | hsa-miR-875-3p | ACSL5 | 0.18 | 0.096 | -0.21 | 0.23881 | PITA; miRNATAP | -0.89 | 0 | NA | |
39 | hsa-miR-1297 | ACSS1 | 0.02 | 0.75457 | 0.19 | 0.04709 | miRanda | -0.29 | 0.04611 | NA | |
40 | hsa-miR-107 | ACTG1 | 0.02 | 0.45295 | 0.13 | 0.04338 | miRanda; miRNATAP | -0.69 | 0.04066 | NA | |
41 | hsa-miR-1224-5p | ACTL6B | 0.15 | 0.23912 | 0.02 | 0.71966 | MirTarget | -0.1 | 0.04303 | NA | |
42 | hsa-miR-324-3p | ACTN4 | -0.15 | 0.01636 | 0.08 | 0.26115 | miRNAWalker2 validate; PITA; miRNATAP | -0.25 | 0.04571 | NA | |
43 | hsa-miR-637 | ACTR1A | 0.19 | 0.15577 | -0.12 | 0.05538 | mirMAP | -0.15 | 0.00387 | NA | |
44 | hsa-miR-342-3p | ACTR3B | -0.2 | 3.0E-5 | 0.28 | 0 | miRanda | -0.51 | 2.0E-5 | NA | |
45 | hsa-miR-188-5p | ACVR2A | 0.48 | 7.0E-5 | -0.4 | 1.0E-5 | PITA | -0.25 | 0.00262 | NA | |
46 | hsa-miR-1275 | ACVRL1 | 0.24 | 0.00451 | -0.74 | 0 | mirMAP | -0.42 | 0.01148 | NA | |
47 | hsa-miR-133b | ADAM12 | -0.56 | 0 | 0.53 | 0.00013 | miRanda | -0.31 | 0.01966 | NA | |
48 | hsa-miR-139-5p | ADAM12 | -0.96 | 0 | 0.53 | 0.00013 | miRanda | -0.19 | 0.04562 | NA | |
49 | hsa-miR-146b-5p | ADAM15 | -0.03 | 0.77608 | 0.15 | 0.02035 | miRanda | -0.2 | 0.01006 | NA | |
50 | hsa-miR-188-5p | ADAM22 | 0.48 | 7.0E-5 | -0.03 | 0.71252 | mirMAP | -0.17 | 0.02779 | NA | |
51 | hsa-miR-484 | ADAM33 | 0.16 | 0.10284 | -0.13 | 0.01251 | MirTarget | -0.16 | 0.00648 | NA | |
52 | hsa-miR-133b | ADAM9 | -0.56 | 0 | 0.31 | 0.0258 | miRanda | -0.27 | 0.0393 | NA | |
53 | hsa-miR-548p | ADAMTS15 | 0.2 | 0.015 | -0.07 | 0.35503 | miRNATAP | -0.21 | 0.04641 | NA | |
54 | hsa-miR-654-5p | ADAMTS17 | 0.2 | 0.03487 | -0.01 | 0.84529 | MirTarget | -0.12 | 0.02029 | NA | |
55 | hsa-miR-1299 | ADAMTS6 | -0.13 | 0.28393 | 0.15 | 0.02621 | MirTarget; PITA | -0.14 | 0.02214 | NA | |
56 | hsa-miR-587 | ADAMTS6 | 0.02 | 0.78578 | 0.15 | 0.02621 | PITA; miRNATAP | -0.24 | 0.02451 | NA | |
57 | hsa-miR-921 | ADAMTS6 | -0.02 | 0.78653 | 0.15 | 0.02621 | MirTarget; PITA; miRNATAP | -0.32 | 0.00595 | NA | |
58 | hsa-miR-1200 | ADARB1 | 0.02 | 0.78612 | 0.02 | 0.7471 | MirTarget; mirMAP; miRNATAP | -0.17 | 0.02188 | NA | |
59 | hsa-miR-518d-5p | ADARB1 | -0.17 | 0.02136 | 0.02 | 0.7471 | MirTarget; miRNATAP | -0.17 | 0.03472 | NA | |
60 | hsa-miR-34c-3p | ADCY2 | 0.08 | 0.32894 | -0.14 | 0.00579 | mirMAP | -0.14 | 0.0416 | NA | |
61 | hsa-miR-342-3p | ADCY3 | -0.2 | 3.0E-5 | 0.41 | 0 | miRanda | -0.58 | 0.00379 | NA | |
62 | hsa-miR-1224-5p | ADCY9 | 0.15 | 0.23912 | -0.4 | 0 | mirMAP | -0.13 | 0.03606 | NA | |
63 | hsa-miR-107 | ADCYAP1 | 0.02 | 0.45295 | -0.11 | 0.05017 | MirTarget; PITA; miRanda; miRNATAP | -0.9 | 0.00075 | NA | |
64 | hsa-miR-324-3p | ADCYAP1 | -0.15 | 0.01636 | -0.11 | 0.05017 | PITA; miRNATAP | -0.23 | 0.0175 | NA | |
65 | hsa-miR-1179 | ADCYAP1R1 | 0.05 | 0.53482 | -0.12 | 0.09847 | mirMAP | -0.25 | 0.01368 | NA | |
66 | hsa-miR-558 | ADGRL1 | -0.15 | 0.04577 | 0.2 | 0.01371 | miRNATAP | -0.27 | 0.02985 | NA | |
67 | hsa-miR-1244 | ADGRL4 | 0.24 | 0.08574 | -0.42 | 0.00469 | MirTarget | -0.28 | 0.02707 | NA | |
68 | hsa-miR-502-5p | ADHFE1 | 0.3 | 0.00093 | -0.6 | 0 | miRNATAP | -0.48 | 0.00012 | NA | |
69 | hsa-miR-612 | ADPRH | 0.07 | 0.39432 | -0.04 | 0.26628 | miRNATAP | -0.14 | 0.0085 | NA | |
70 | hsa-miR-107 | ADRB2 | 0.02 | 0.45295 | -0.16 | 0.00256 | miRanda | -0.55 | 0.04248 | NA | |
71 | hsa-miR-1275 | ADRB2 | 0.24 | 0.00451 | -0.16 | 0.00256 | MirTarget | -0.15 | 0.0338 | NA | |
72 | hsa-miR-1283 | ADSS | -0.15 | 0.08004 | 0.21 | 0.02668 | MirTarget; PITA | -0.26 | 0.04606 | NA | |
73 | hsa-miR-1303 | AFF1 | 0.15 | 0.048 | -0.42 | 0 | mirMAP | -0.3 | 0.01218 | NA | |
74 | hsa-miR-875-3p | AFF1 | 0.18 | 0.096 | -0.42 | 0 | PITA | -0.17 | 0.03928 | NA | |
75 | hsa-miR-107 | AFF2 | 0.02 | 0.45295 | -0.06 | 0.2719 | mirMAP; miRNATAP | -0.63 | 0.02323 | NA | |
76 | hsa-miR-1179 | AFF2 | 0.05 | 0.53482 | -0.06 | 0.2719 | mirMAP | -0.2 | 0.00746 | NA | |
77 | hsa-miR-548p | AFF2 | 0.2 | 0.015 | -0.06 | 0.2719 | mirMAP | -0.18 | 0.01428 | NA | |
78 | hsa-miR-600 | AFF2 | 0.01 | 0.90987 | -0.06 | 0.2719 | PITA; mirMAP | -0.23 | 0.00315 | NA | |
79 | hsa-miR-525-5p | AFF4 | -0.03 | 0.64643 | -0.05 | 0.47883 | MirTarget; PITA | -0.27 | 0.02075 | NA | |
80 | hsa-miR-342-3p | AFMID | -0.2 | 3.0E-5 | 0.28 | 0 | miRanda | -0.31 | 0.0192 | NA | |
81 | hsa-miR-129-5p | AGAP6 | 0.13 | 0.23985 | 0.25 | 0.07098 | miRanda | -0.33 | 0.02593 | NA | |
82 | hsa-miR-622 | AGFG2 | 0.32 | 0.00092 | -0.14 | 0.02367 | mirMAP | -0.15 | 0.03176 | NA | |
83 | hsa-miR-875-3p | AGFG2 | 0.18 | 0.096 | -0.14 | 0.02367 | miRNATAP | -0.22 | 0.00073 | NA | |
84 | hsa-miR-146b-3p | AGGF1 | 0.1 | 0.33957 | -0.13 | 0.0581 | miRNATAP | -0.17 | 0.02146 | NA | |
85 | hsa-miR-558 | AGO2 | -0.15 | 0.04577 | 0.62 | 0 | miRNATAP | -0.41 | 0.01325 | NA | |
86 | hsa-miR-133b | AHCY | -0.56 | 0 | 0.85 | 0 | miRanda | -0.48 | 7.0E-5 | NA | |
87 | hsa-miR-1253 | AHCYL1 | 0 | 0.96973 | -0.14 | 0.06228 | PITA; miRNATAP | -0.25 | 0.03423 | NA | |
88 | hsa-miR-875-3p | AHCYL2 | 0.18 | 0.096 | -1.65 | 0 | mirMAP | -0.76 | 0.00485 | NA | |
89 | hsa-miR-875-3p | AHNAK | 0.18 | 0.096 | -1.18 | 0 | PITA | -0.46 | 0.0226 | NA | |
90 | hsa-miR-558 | AIG1 | -0.15 | 0.04577 | 0.26 | 0.00513 | miRNATAP | -0.29 | 0.04277 | NA | |
91 | hsa-miR-525-5p | AIM1 | -0.03 | 0.64643 | -0.18 | 0.10342 | miRNATAP | -0.35 | 0.04945 | NA | |
92 | hsa-miR-548b-3p | AK4 | -0.13 | 0.08239 | 0.21 | 0.03542 | mirMAP | -0.35 | 0.02197 | NA | |
93 | hsa-miR-875-3p | AK7 | 0.18 | 0.096 | -0.06 | 0.2184 | PITA | -0.12 | 0.01237 | NA | |
94 | hsa-miR-637 | AKAP13 | 0.19 | 0.15577 | -0.46 | 0 | mirMAP | -0.16 | 0.02482 | NA | |
95 | hsa-miR-665 | AKAP13 | 0.29 | 0.01654 | -0.46 | 0 | miRNATAP | -0.23 | 0.00218 | NA | |
96 | hsa-miR-1289 | AKIRIN1 | 0.1 | 0.12893 | -0.04 | 0.44188 | miRNATAP | -0.21 | 0.02586 | NA | |
97 | hsa-miR-369-3p | AKT1 | -0.05 | 0.45428 | 0.05 | 0.23182 | miRNATAP | -0.13 | 0.03641 | NA | |
98 | hsa-miR-342-3p | AKT2 | -0.2 | 3.0E-5 | 0.13 | 0.01365 | mirMAP | -0.26 | 0.0332 | NA | |
99 | hsa-miR-1275 | AKT3 | 0.24 | 0.00451 | -0.69 | 1.0E-5 | PITA | -0.55 | 0.01043 | NA | |
100 | hsa-miR-637 | AKT3 | 0.19 | 0.15577 | -0.69 | 1.0E-5 | PITA | -0.3 | 0.02663 | NA | |
101 | hsa-miR-324-3p | ALDOA | -0.15 | 0.01636 | 0.18 | 0.00366 | miRNAWalker2 validate | -0.24 | 0.03509 | NA | |
102 | hsa-miR-1303 | ALG10B | 0.15 | 0.048 | -0.1 | 0.37752 | MirTarget | -0.5 | 0.00387 | NA | |
103 | hsa-miR-661 | ALOX15 | 0.05 | 0.57941 | 0.01 | 0.91189 | PITA | -0.19 | 0.02666 | NA | |
104 | hsa-miR-1825 | ALS2 | -0.09 | 0.2173 | 0.13 | 0.0695 | miRNATAP | -0.29 | 0.00967 | NA | |
105 | hsa-miR-548c-3p | AMER1 | -0.1 | 0.19562 | 0.31 | 1.0E-5 | miRNATAP | -0.22 | 0.03373 | NA | |
106 | hsa-miR-342-3p | AMMECR1L | -0.2 | 3.0E-5 | 0.23 | 0.00049 | mirMAP | -0.44 | 0.00599 | NA | |
107 | hsa-miR-330-3p | AMOT | -0.09 | 0.47557 | 0.29 | 0.01112 | MirTarget; PITA; miRNATAP | -0.24 | 0.01808 | NA | |
108 | hsa-miR-875-3p | AMOT | 0.18 | 0.096 | 0.29 | 0.01112 | MirTarget | -0.29 | 0.01365 | NA | |
109 | hsa-miR-1275 | AMOTL1 | 0.24 | 0.00451 | -0.17 | 0.0013 | miRNATAP | -0.18 | 0.01113 | NA | |
110 | hsa-miR-330-3p | AMOTL2 | -0.09 | 0.47557 | 0.13 | 0.01176 | mirMAP | -0.13 | 0.00174 | NA | |
111 | hsa-miR-139-5p | ANAPC7 | -0.96 | 0 | 0.4 | 0 | miRanda | -0.2 | 1.0E-5 | NA | |
112 | hsa-miR-548c-3p | ANGEL1 | -0.1 | 0.19562 | 0.32 | 1.0E-5 | MirTarget; PITA; mirMAP | -0.22 | 0.03941 | NA | |
113 | hsa-miR-133b | ANGPT2 | -0.56 | 0 | 0.42 | 0.00033 | miRanda | -0.28 | 0.01366 | NA | |
114 | hsa-miR-1283 | ANGPTL5 | -0.15 | 0.08004 | 0.03 | 0.49375 | MirTarget; miRNATAP | -0.12 | 0.03433 | NA | |
115 | hsa-miR-1179 | ANK1 | 0.05 | 0.53482 | 0.11 | 0.05395 | PITA; miRNATAP | -0.16 | 0.03152 | NA | |
116 | hsa-miR-600 | ANK1 | 0.01 | 0.90987 | 0.11 | 0.05395 | PITA; miRNATAP | -0.19 | 0.01225 | NA | |
117 | hsa-miR-1275 | ANK2 | 0.24 | 0.00451 | -1.01 | 0 | MirTarget | -0.61 | 0.00114 | NA | |
118 | hsa-miR-502-5p | ANK2 | 0.3 | 0.00093 | -1.01 | 0 | PITA | -0.6 | 0.0004 | NA | |
119 | hsa-miR-575 | ANK3 | 0.18 | 0.03642 | -0.55 | 0 | MirTarget; PITA | -0.3 | 0.03031 | NA | |
120 | hsa-miR-129-5p | ANKH | 0.13 | 0.23985 | 0.14 | 0.13002 | miRanda | -0.2 | 0.03214 | NA | |
121 | hsa-miR-623 | ANKH | -0.03 | 0.66704 | 0.14 | 0.13002 | mirMAP | -0.3 | 0.04457 | NA | |
122 | hsa-miR-601 | ANKIB1 | -0.23 | 0.0006 | 0.18 | 0.03225 | miRNATAP | -0.35 | 0.01661 | NA | |
123 | hsa-miR-342-3p | ANKLE2 | -0.2 | 3.0E-5 | 0.22 | 0.00015 | miRanda | -0.35 | 0.01056 | NA | |
124 | hsa-miR-188-5p | ANKRD12 | 0.48 | 7.0E-5 | -0.92 | 0 | PITA | -0.45 | 0.00061 | NA | |
125 | hsa-miR-502-5p | ANKRD12 | 0.3 | 0.00093 | -0.92 | 0 | PITA; miRNATAP | -0.51 | 0.00501 | NA | |
126 | hsa-miR-188-5p | ANKRD13A | 0.48 | 7.0E-5 | -0.5 | 0 | mirMAP | -0.22 | 0.00529 | NA | |
127 | hsa-miR-548c-3p | ANKRD18B | -0.1 | 0.19562 | 0.18 | 0.00767 | MirTarget | -0.27 | 0.00513 | NA | |
128 | hsa-miR-139-5p | ANKRD27 | -0.96 | 0 | 0.25 | 0.00012 | miRanda | -0.1 | 0.01931 | NA | |
129 | hsa-miR-1253 | ANKRD28 | 0 | 0.96973 | -0.17 | 0.07767 | PITA; miRNATAP | -0.3 | 0.04496 | NA | |
130 | hsa-miR-520h | ANKRD36 | -0.03 | 0.73371 | -0.03 | 0.84136 | mirMAP | -0.51 | 0.03572 | NA | |
131 | hsa-miR-133b | ANKRD46 | -0.56 | 0 | 0.3 | 0.00622 | miRanda | -0.25 | 0.01592 | NA | |
132 | hsa-miR-1253 | ANKRD49 | 0 | 0.96973 | -0.03 | 0.75692 | MirTarget; miRNATAP | -0.35 | 0.04139 | NA | |
133 | hsa-miR-342-3p | ANKRD52 | -0.2 | 3.0E-5 | 0.17 | 0.0025 | PITA; miRNATAP | -0.39 | 0.00243 | NA | |
134 | hsa-miR-139-5p | ANKS1A | -0.96 | 0 | 0.14 | 0.02401 | miRanda | -0.11 | 0.00827 | NA | |
135 | hsa-miR-558 | ANKS6 | -0.15 | 0.04577 | 0.38 | 0 | mirMAP | -0.23 | 0.02942 | NA | |
136 | hsa-miR-342-3p | ANLN | -0.2 | 3.0E-5 | 1.35 | 0 | miRanda | -1.97 | 0.00013 | NA | |
137 | hsa-miR-637 | ANO10 | 0.19 | 0.15577 | -0.55 | 0 | MirTarget | -0.23 | 0.01084 | NA | |
138 | hsa-miR-1179 | ANO3 | 0.05 | 0.53482 | -0 | 0.96333 | MirTarget; miRNATAP | -0.2 | 0.00968 | NA | |
139 | hsa-miR-558 | ANP32A | -0.15 | 0.04577 | 0.1 | 0.10261 | miRNATAP | -0.18 | 0.03603 | NA | |
140 | hsa-miR-558 | ANP32E | -0.15 | 0.04577 | -0.05 | 0.65057 | miRNATAP | -0.34 | 0.03538 | NA | |
141 | hsa-miR-296-3p | ANTXR1 | -0.06 | 0.54339 | -0.15 | 0.28155 | MirTarget; PITA; miRanda | -0.52 | 0.00147 | NA | |
142 | hsa-miR-409-3p | ANXA11 | -0.01 | 0.91657 | -0.1 | 0.19622 | mirMAP | -0.2 | 0.0253 | NA | |
143 | hsa-miR-484 | ANXA11 | 0.16 | 0.10284 | -0.1 | 0.19622 | miRNAWalker2 validate; mirMAP | -0.2 | 0.02336 | NA | |
144 | hsa-miR-654-5p | ANXA11 | 0.2 | 0.03487 | -0.1 | 0.19622 | MirTarget | -0.19 | 0.04292 | NA | |
145 | hsa-miR-1303 | AP1AR | 0.15 | 0.048 | -0.03 | 0.78385 | MirTarget | -0.3 | 0.03145 | NA | |
146 | hsa-miR-129-5p | AP1G1 | 0.13 | 0.23985 | -0.16 | 0.02465 | mirMAP | -0.21 | 0.00361 | NA | |
147 | hsa-miR-665 | AP1G1 | 0.29 | 0.01654 | -0.16 | 0.02465 | PITA; miRNATAP | -0.13 | 0.03849 | NA | |
148 | hsa-miR-139-5p | AP1S1 | -0.96 | 0 | 0.64 | 0 | miRanda | -0.24 | 0.00445 | NA | |
149 | hsa-miR-342-3p | AP2A1 | -0.2 | 3.0E-5 | 0.13 | 0.01203 | miRanda | -0.26 | 0.03436 | NA | |
150 | hsa-miR-607 | AP2B1 | -0.07 | 0.34593 | 0.13 | 0.15931 | miRNATAP | -0.31 | 0.02535 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | POSITIVE REGULATION OF GENE EXPRESSION | 390 | 1733 | 7.477e-23 | 3.479e-19 |
2 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 394 | 1784 | 1.63e-21 | 3.793e-18 |
3 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 395 | 1805 | 8.118e-21 | 1.259e-17 |
4 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 147 | 554 | 7.197e-15 | 8.008e-12 |
5 | REGULATION OF ORGANELLE ORGANIZATION | 262 | 1178 | 8.605e-15 | 8.008e-12 |
6 | CELL DEVELOPMENT | 303 | 1426 | 3.045e-14 | 2.362e-11 |
7 | EMBRYO DEVELOPMENT | 208 | 894 | 6.183e-14 | 3.596e-11 |
8 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 228 | 1004 | 5.564e-14 | 3.596e-11 |
9 | NEUROGENESIS | 297 | 1402 | 8.398e-14 | 4.342e-11 |
10 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 342 | 1672 | 1.339e-13 | 6.231e-11 |
11 | NEGATIVE REGULATION OF GENE EXPRESSION | 311 | 1493 | 1.918e-13 | 8.111e-11 |
12 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 217 | 957 | 2.768e-13 | 1.073e-10 |
13 | TISSUE DEVELOPMENT | 310 | 1518 | 2.697e-12 | 9.655e-10 |
14 | EMBRYONIC MORPHOGENESIS | 136 | 539 | 4.206e-12 | 1.398e-09 |
15 | REGULATION OF CELL DIFFERENTIATION | 302 | 1492 | 1.57e-11 | 4.871e-09 |
16 | REGULATION OF CELL DEVELOPMENT | 188 | 836 | 2.504e-11 | 7.281e-09 |
17 | POSITIVE REGULATION OF CELL COMMUNICATION | 307 | 1532 | 3.498e-11 | 9.575e-09 |
18 | RESPONSE TO ENDOGENOUS STIMULUS | 292 | 1450 | 6.408e-11 | 1.569e-08 |
19 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 219 | 1021 | 6.149e-11 | 1.569e-08 |
20 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 303 | 1517 | 7.011e-11 | 1.631e-08 |
21 | PROTEIN LOCALIZATION | 350 | 1805 | 9.026e-11 | 2e-08 |
22 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 174 | 771 | 1.058e-10 | 2.237e-08 |
23 | REGULATION OF CYTOSKELETON ORGANIZATION | 124 | 502 | 1.646e-10 | 3.33e-08 |
24 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 346 | 1791 | 1.866e-10 | 3.524e-08 |
25 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 176 | 788 | 1.969e-10 | 3.524e-08 |
26 | CIRCULATORY SYSTEM DEVELOPMENT | 176 | 788 | 1.969e-10 | 3.524e-08 |
27 | ORGAN MORPHOGENESIS | 185 | 841 | 2.477e-10 | 4.269e-08 |
28 | MUSCLE STRUCTURE DEVELOPMENT | 110 | 432 | 2.711e-10 | 4.505e-08 |
29 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 125 | 513 | 3.524e-10 | 5.655e-08 |
30 | INTRACELLULAR SIGNAL TRANSDUCTION | 308 | 1572 | 4.463e-10 | 6.77e-08 |
31 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 213 | 1008 | 4.581e-10 | 6.77e-08 |
32 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 166 | 740 | 4.656e-10 | 6.77e-08 |
33 | NEURON DIFFERENTIATION | 189 | 874 | 6.819e-10 | 9.332e-08 |
34 | MUSCLE CELL DIFFERENTIATION | 70 | 237 | 6.654e-10 | 9.332e-08 |
35 | TUBE FORMATION | 46 | 129 | 7.843e-10 | 1.043e-07 |
36 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 371 | 1977 | 1.511e-09 | 1.954e-07 |
37 | ESTABLISHMENT OF LOCALIZATION IN CELL | 322 | 1676 | 1.643e-09 | 2.066e-07 |
38 | REGULATION OF CELLULAR RESPONSE TO STRESS | 155 | 691 | 1.787e-09 | 2.189e-07 |
39 | HEAD DEVELOPMENT | 158 | 709 | 2.024e-09 | 2.415e-07 |
40 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 165 | 750 | 2.367e-09 | 2.754e-07 |
41 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 362 | 1929 | 2.468e-09 | 2.801e-07 |
42 | NEURON PROJECTION DEVELOPMENT | 128 | 545 | 2.581e-09 | 2.859e-07 |
43 | CELLULAR COMPONENT MORPHOGENESIS | 190 | 900 | 4.511e-09 | 4.881e-07 |
44 | RESPONSE TO GROWTH FACTOR | 114 | 475 | 5.306e-09 | 5.611e-07 |
45 | TUBE MORPHOGENESIS | 85 | 323 | 5.518e-09 | 5.706e-07 |
46 | PROTEIN PHOSPHORYLATION | 197 | 944 | 6.045e-09 | 5.984e-07 |
47 | NEURAL TUBE FORMATION | 36 | 94 | 5.995e-09 | 5.984e-07 |
48 | REGULATION OF DEVELOPMENTAL GROWTH | 78 | 289 | 6.978e-09 | 6.764e-07 |
49 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 315 | 1656 | 7.497e-09 | 6.977e-07 |
50 | REGULATION OF NEURON DIFFERENTIATION | 128 | 554 | 7.445e-09 | 6.977e-07 |
51 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 307 | 1618 | 1.548e-08 | 1.412e-06 |
52 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 170 | 799 | 1.702e-08 | 1.523e-06 |
53 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 164 | 767 | 2.152e-08 | 1.887e-06 |
54 | REGULATION OF PROTEIN MODIFICATION PROCESS | 321 | 1710 | 2.19e-08 | 1.887e-06 |
55 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 182 | 872 | 2.316e-08 | 1.959e-06 |
56 | CELL PROLIFERATION | 147 | 672 | 2.631e-08 | 2.186e-06 |
57 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 156 | 724 | 2.823e-08 | 2.304e-06 |
58 | EPITHELIUM DEVELOPMENT | 194 | 945 | 2.922e-08 | 2.309e-06 |
59 | CELL CYCLE | 256 | 1316 | 2.978e-08 | 2.309e-06 |
60 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 226 | 1135 | 2.938e-08 | 2.309e-06 |
61 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 227 | 1142 | 3.169e-08 | 2.417e-06 |
62 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 249 | 1275 | 3.288e-08 | 2.468e-06 |
63 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 209 | 1036 | 3.524e-08 | 2.562e-06 |
64 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 209 | 1036 | 3.524e-08 | 2.562e-06 |
65 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 273 | 1423 | 3.767e-08 | 2.697e-06 |
66 | REGULATION OF CELL PROJECTION ORGANIZATION | 126 | 558 | 4.016e-08 | 2.831e-06 |
67 | GLAND DEVELOPMENT | 96 | 395 | 4.443e-08 | 3.086e-06 |
68 | REGULATION OF GROWTH | 139 | 633 | 4.951e-08 | 3.338e-06 |
69 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 341 | 1848 | 4.906e-08 | 3.338e-06 |
70 | PEPTIDYL AMINO ACID MODIFICATION | 175 | 841 | 5.412e-08 | 3.597e-06 |
71 | CHROMATIN MODIFICATION | 122 | 539 | 5.726e-08 | 3.753e-06 |
72 | CELLULAR RESPONSE TO LIPID | 107 | 457 | 6.16e-08 | 3.981e-06 |
73 | NEURON DEVELOPMENT | 148 | 687 | 6.507e-08 | 4.06e-06 |
74 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 227 | 1152 | 6.615e-08 | 4.06e-06 |
75 | REGULATION OF CELL CYCLE | 193 | 949 | 6.541e-08 | 4.06e-06 |
76 | CELL PROJECTION ORGANIZATION | 185 | 902 | 6.632e-08 | 4.06e-06 |
77 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 147 | 684 | 8.426e-08 | 5.091e-06 |
78 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 43 | 134 | 9.642e-08 | 5.752e-06 |
79 | TUBE DEVELOPMENT | 123 | 552 | 1.265e-07 | 7.355e-06 |
80 | REGULATION OF CELL MORPHOGENESIS | 123 | 552 | 1.265e-07 | 7.355e-06 |
81 | STRIATED MUSCLE CELL DIFFERENTIATION | 51 | 173 | 1.418e-07 | 8.148e-06 |
82 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 285 | 1518 | 1.457e-07 | 8.27e-06 |
83 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 265 | 1395 | 1.482e-07 | 8.31e-06 |
84 | REGULATION OF EMBRYONIC DEVELOPMENT | 38 | 114 | 1.751e-07 | 9.697e-06 |
85 | CELLULAR MACROMOLECULE LOCALIZATION | 238 | 1234 | 1.942e-07 | 1.057e-05 |
86 | PHOSPHORYLATION | 237 | 1228 | 1.953e-07 | 1.057e-05 |
87 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 96 | 408 | 2.278e-07 | 1.205e-05 |
88 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 122 | 552 | 2.262e-07 | 1.205e-05 |
89 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 279 | 1492 | 2.868e-07 | 1.499e-05 |
90 | ENDOMEMBRANE SYSTEM ORGANIZATION | 106 | 465 | 2.915e-07 | 1.507e-05 |
91 | MORPHOGENESIS OF AN EPITHELIUM | 94 | 400 | 3.223e-07 | 1.642e-05 |
92 | SKELETAL SYSTEM DEVELOPMENT | 104 | 455 | 3.282e-07 | 1.642e-05 |
93 | HEART DEVELOPMENT | 106 | 466 | 3.257e-07 | 1.642e-05 |
94 | ACTIN FILAMENT BASED PROCESS | 103 | 450 | 3.481e-07 | 1.723e-05 |
95 | REGULATION OF CELL PROLIFERATION | 279 | 1496 | 3.646e-07 | 1.786e-05 |
96 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 82 | 337 | 3.97e-07 | 1.924e-05 |
97 | POSITIVE REGULATION OF GROWTH | 63 | 238 | 4.013e-07 | 1.925e-05 |
98 | NEURON PROJECTION MORPHOGENESIS | 94 | 402 | 4.094e-07 | 1.944e-05 |
99 | REPRODUCTIVE SYSTEM DEVELOPMENT | 95 | 408 | 4.363e-07 | 2.051e-05 |
100 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 77 | 312 | 4.888e-07 | 2.264e-05 |
101 | LOCOMOTION | 216 | 1114 | 4.914e-07 | 2.264e-05 |
102 | NUCLEAR TRANSPORT | 85 | 355 | 5.088e-07 | 2.321e-05 |
103 | POSITIVE REGULATION OF KINASE ACTIVITY | 108 | 482 | 5.52e-07 | 2.446e-05 |
104 | RESPONSE TO HORMONE | 179 | 893 | 5.433e-07 | 2.446e-05 |
105 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 183 | 917 | 5.501e-07 | 2.446e-05 |
106 | REGULATION OF TRANSPORT | 327 | 1804 | 5.644e-07 | 2.477e-05 |
107 | TISSUE MORPHOGENESIS | 117 | 533 | 5.756e-07 | 2.48e-05 |
108 | BEHAVIOR | 114 | 516 | 5.715e-07 | 2.48e-05 |
109 | REGULATION OF EPITHELIAL CELL MIGRATION | 48 | 166 | 6.119e-07 | 2.578e-05 |
110 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 48 | 166 | 6.119e-07 | 2.578e-05 |
111 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 129 | 602 | 6.15e-07 | 2.578e-05 |
112 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 259 | 1381 | 6.205e-07 | 2.578e-05 |
113 | LOCOMOTORY BEHAVIOR | 51 | 181 | 6.617e-07 | 2.725e-05 |
114 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 87 | 368 | 6.685e-07 | 2.728e-05 |
115 | MITOTIC CELL CYCLE | 157 | 766 | 6.956e-07 | 2.814e-05 |
116 | POSITIVE REGULATION OF CELL PROLIFERATION | 165 | 814 | 7.445e-07 | 2.986e-05 |
117 | RESPONSE TO OXYGEN LEVELS | 76 | 311 | 8.717e-07 | 3.467e-05 |
118 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 175 | 876 | 9.123e-07 | 3.597e-05 |
119 | NEURAL TUBE DEVELOPMENT | 44 | 149 | 9.428e-07 | 3.615e-05 |
120 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 101 | 448 | 9.478e-07 | 3.615e-05 |
121 | CELL CYCLE PROCESS | 209 | 1081 | 9.365e-07 | 3.615e-05 |
122 | DEVELOPMENTAL GROWTH | 80 | 333 | 9.447e-07 | 3.615e-05 |
123 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 34 | 103 | 9.862e-07 | 3.731e-05 |
124 | GROWTH | 94 | 410 | 1.035e-06 | 3.882e-05 |
125 | REGULATION OF PROTEIN LOCALIZATION | 187 | 950 | 1.071e-06 | 3.985e-05 |
126 | BIOLOGICAL ADHESION | 200 | 1032 | 1.37e-06 | 5.06e-05 |
127 | RESPONSE TO LIPID | 176 | 888 | 1.43e-06 | 5.238e-05 |
128 | VASCULATURE DEVELOPMENT | 104 | 469 | 1.48e-06 | 5.379e-05 |
129 | REGULATION OF KINASE ACTIVITY | 157 | 776 | 1.553e-06 | 5.601e-05 |
130 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 83 | 354 | 1.704e-06 | 6.099e-05 |
131 | REGULATION OF MAPK CASCADE | 137 | 660 | 1.756e-06 | 6.238e-05 |
132 | TELENCEPHALON DEVELOPMENT | 59 | 228 | 2.053e-06 | 7.237e-05 |
133 | CELLULAR RESPONSE TO HORMONE STIMULUS | 118 | 552 | 2.083e-06 | 7.287e-05 |
134 | REGULATION OF DENDRITE DEVELOPMENT | 37 | 120 | 2.175e-06 | 7.552e-05 |
135 | CHROMOSOME ORGANIZATION | 195 | 1009 | 2.253e-06 | 7.764e-05 |
136 | EMBRYONIC ORGAN DEVELOPMENT | 92 | 406 | 2.271e-06 | 7.77e-05 |
137 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 164 | 823 | 2.352e-06 | 7.987e-05 |
138 | FOREBRAIN DEVELOPMENT | 83 | 357 | 2.431e-06 | 8.198e-05 |
139 | NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 53 | 199 | 2.654e-06 | 8.884e-05 |
140 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 141 | 689 | 2.797e-06 | 9.296e-05 |
141 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 103 | 470 | 2.904e-06 | 9.584e-05 |
142 | CYTOSKELETON ORGANIZATION | 166 | 838 | 2.948e-06 | 9.66e-05 |
143 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 33 | 103 | 2.984e-06 | 9.708e-05 |
144 | CELLULAR RESPONSE TO STRESS | 284 | 1565 | 3.073e-06 | 9.93e-05 |
145 | CHONDROCYTE DIFFERENTIATION | 23 | 60 | 3.173e-06 | 0.0001015 |
146 | POSITIVE REGULATION OF CELL CYCLE | 78 | 332 | 3.185e-06 | 0.0001015 |
147 | CELL DIVISION | 101 | 460 | 3.31e-06 | 0.0001048 |
148 | IN UTERO EMBRYONIC DEVELOPMENT | 74 | 311 | 3.459e-06 | 0.0001088 |
149 | CELL MOTILITY | 165 | 835 | 3.668e-06 | 0.000113 |
150 | LOCALIZATION OF CELL | 165 | 835 | 3.668e-06 | 0.000113 |
151 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 44 | 156 | 3.651e-06 | 0.000113 |
152 | CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 14 | 27 | 4.128e-06 | 0.0001264 |
153 | MUSCLE TISSUE DEVELOPMENT | 67 | 275 | 4.217e-06 | 0.0001274 |
154 | NUCLEAR EXPORT | 42 | 147 | 4.205e-06 | 0.0001274 |
155 | SINGLE ORGANISM BEHAVIOR | 87 | 384 | 4.264e-06 | 0.000128 |
156 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 45 | 162 | 4.442e-06 | 0.0001325 |
157 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 107 | 498 | 4.839e-06 | 0.0001434 |
158 | SENSORY ORGAN DEVELOPMENT | 106 | 493 | 5.178e-06 | 0.0001525 |
159 | SEX DIFFERENTIATION | 65 | 266 | 5.244e-06 | 0.0001535 |
160 | REGULATION OF OSSIFICATION | 48 | 178 | 5.324e-06 | 0.0001548 |
161 | CELL JUNCTION ASSEMBLY | 38 | 129 | 5.392e-06 | 0.0001558 |
162 | REGULATION OF CELLULAR COMPONENT SIZE | 78 | 337 | 5.753e-06 | 0.0001652 |
163 | CHROMATIN ORGANIZATION | 135 | 663 | 5.936e-06 | 0.0001694 |
164 | REGULATION OF CHROMOSOME ORGANIZATION | 67 | 278 | 6.235e-06 | 0.0001769 |
165 | ADULT BEHAVIOR | 39 | 135 | 6.837e-06 | 0.0001928 |
166 | RNA LOCALIZATION | 49 | 185 | 7.329e-06 | 0.0002054 |
167 | CELL PART MORPHOGENESIS | 129 | 633 | 9.111e-06 | 0.0002539 |
168 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 126 | 616 | 9.597e-06 | 0.0002658 |
169 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 51 | 197 | 9.68e-06 | 0.0002665 |
170 | PROTEIN AUTOPHOSPHORYLATION | 50 | 192 | 9.886e-06 | 0.0002706 |
171 | CARTILAGE DEVELOPMENT | 41 | 147 | 1.04e-05 | 0.0002813 |
172 | CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 12 | 22 | 1.034e-05 | 0.0002813 |
173 | IMMUNE SYSTEM DEVELOPMENT | 120 | 582 | 1.057e-05 | 0.0002824 |
174 | POSITIVE REGULATION OF CELL DEVELOPMENT | 101 | 472 | 1.059e-05 | 0.0002824 |
175 | EPITHELIAL CELL DIFFERENTIATION | 105 | 495 | 1.062e-05 | 0.0002824 |
176 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 22 | 60 | 1.197e-05 | 0.0003165 |
177 | OSSIFICATION | 61 | 251 | 1.207e-05 | 0.0003173 |
178 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 34 | 114 | 1.231e-05 | 0.0003217 |
179 | REGULATION OF CELL DEATH | 265 | 1472 | 1.242e-05 | 0.0003229 |
180 | APPENDAGE DEVELOPMENT | 45 | 169 | 1.466e-05 | 0.000377 |
181 | LIMB DEVELOPMENT | 45 | 169 | 1.466e-05 | 0.000377 |
182 | WNT SIGNALING PATHWAY | 79 | 351 | 1.484e-05 | 0.0003795 |
183 | CELL JUNCTION ORGANIZATION | 48 | 185 | 1.637e-05 | 0.0004139 |
184 | REGULATION OF CELL CYCLE PROCESS | 115 | 558 | 1.637e-05 | 0.0004139 |
185 | REGULATION OF DENDRITE MORPHOGENESIS | 25 | 74 | 1.646e-05 | 0.0004139 |
186 | REGULATION OF CELLULAR LOCALIZATION | 233 | 1277 | 1.714e-05 | 0.0004288 |
187 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 100 | 472 | 1.798e-05 | 0.0004473 |
188 | NITROGEN COMPOUND TRANSPORT | 106 | 507 | 1.849e-05 | 0.0004576 |
189 | DENDRITE DEVELOPMENT | 26 | 79 | 1.904e-05 | 0.0004645 |
190 | EPITHELIAL CELL DEVELOPMENT | 48 | 186 | 1.907e-05 | 0.0004645 |
191 | NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 85 | 387 | 1.897e-05 | 0.0004645 |
192 | NEGATIVE REGULATION OF CELL CYCLE | 93 | 433 | 2.002e-05 | 0.0004852 |
193 | ACTIN FILAMENT BASED MOVEMENT | 29 | 93 | 2.075e-05 | 0.0004994 |
194 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 39 | 141 | 2.082e-05 | 0.0004994 |
195 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 80 | 360 | 2.131e-05 | 0.0005085 |
196 | POSITIVE REGULATION OF OSSIFICATION | 27 | 84 | 2.152e-05 | 0.0005109 |
197 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 33 | 112 | 2.167e-05 | 0.0005119 |
198 | TRNA TRANSPORT | 15 | 34 | 2.3e-05 | 0.0005406 |
199 | RESPONSE TO WOUNDING | 115 | 563 | 2.47e-05 | 0.0005774 |
200 | REGULATION OF CHROMATIN ORGANIZATION | 41 | 152 | 2.482e-05 | 0.0005775 |
201 | POSITIVE REGULATION OF MAPK CASCADE | 99 | 470 | 2.524e-05 | 0.0005842 |
202 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 70 | 306 | 2.546e-05 | 0.0005865 |
203 | PALATE DEVELOPMENT | 27 | 85 | 2.732e-05 | 0.0006263 |
204 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 54 | 220 | 2.769e-05 | 0.0006316 |
205 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 59 | 247 | 2.869e-05 | 0.0006511 |
206 | REGULATION OF ORGAN MORPHOGENESIS | 58 | 242 | 3.01e-05 | 0.00068 |
207 | NEURON PROJECTION GUIDANCE | 51 | 205 | 3.113e-05 | 0.0006997 |
208 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 116 | 573 | 3.431e-05 | 0.0007675 |
209 | STEM CELL DIFFERENTIATION | 48 | 190 | 3.45e-05 | 0.0007681 |
210 | RESPONSE TO STEROID HORMONE | 103 | 497 | 3.51e-05 | 0.0007777 |
211 | REGULATION OF SODIUM ION TRANSPORT | 25 | 77 | 3.545e-05 | 0.0007817 |
212 | MEMBRANE DISASSEMBLY | 18 | 47 | 3.728e-05 | 0.0008143 |
213 | NUCLEAR ENVELOPE DISASSEMBLY | 18 | 47 | 3.728e-05 | 0.0008143 |
214 | MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS | 13 | 28 | 4.18e-05 | 0.0009088 |
215 | REGULATION OF BINDING | 65 | 283 | 4.27e-05 | 0.0009242 |
216 | REGIONALIZATION | 70 | 311 | 4.422e-05 | 0.0009526 |
217 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 97 | 465 | 4.504e-05 | 0.0009659 |
218 | POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 10 | 18 | 4.715e-05 | 0.001006 |
219 | PROTEIN LOCALIZATION TO NUCLEUS | 41 | 156 | 4.77e-05 | 0.001013 |
220 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 34 | 121 | 4.834e-05 | 0.001022 |
221 | CHEMICAL HOMEOSTASIS | 165 | 874 | 5.041e-05 | 0.001056 |
222 | POSITIVE REGULATION OF LOCOMOTION | 89 | 420 | 5.037e-05 | 0.001056 |
223 | EMBRYONIC ORGAN MORPHOGENESIS | 64 | 279 | 5.07e-05 | 0.001058 |
224 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 52 | 214 | 5.141e-05 | 0.001068 |
225 | REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 18 | 48 | 5.179e-05 | 0.001071 |
226 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 17 | 44 | 5.347e-05 | 0.001101 |
227 | RESPONSE TO ACID CHEMICAL | 71 | 319 | 5.719e-05 | 0.001167 |
228 | REGULATION OF MAP KINASE ACTIVITY | 71 | 319 | 5.719e-05 | 0.001167 |
229 | REGULATION OF PROTEIN POLYMERIZATION | 44 | 173 | 6.039e-05 | 0.001227 |
230 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 48 | 194 | 6.071e-05 | 0.001228 |
231 | REGULATION OF TRANSFERASE ACTIVITY | 176 | 946 | 6.503e-05 | 0.00131 |
232 | REGULATION OF RESPONSE TO STRESS | 259 | 1468 | 6.609e-05 | 0.00132 |
233 | REGULATION OF CELL CYCLE ARREST | 31 | 108 | 6.589e-05 | 0.00132 |
234 | REPRODUCTION | 232 | 1297 | 6.72e-05 | 0.001336 |
235 | REGULATION OF STEM CELL DIFFERENTIATION | 32 | 113 | 6.752e-05 | 0.001337 |
236 | REGULATION OF MRNA METABOLIC PROCESS | 33 | 118 | 6.868e-05 | 0.001343 |
237 | RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 33 | 118 | 6.868e-05 | 0.001343 |
238 | RAS PROTEIN SIGNAL TRANSDUCTION | 38 | 143 | 6.862e-05 | 0.001343 |
239 | REGULATION OF WNT SIGNALING PATHWAY | 69 | 310 | 7.207e-05 | 0.001403 |
240 | MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY | 15 | 37 | 7.629e-05 | 0.001479 |
241 | HEART MORPHOGENESIS | 51 | 212 | 7.956e-05 | 0.001536 |
242 | CELL CELL ADHESION | 120 | 608 | 8.017e-05 | 0.001541 |
243 | POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 44 | 175 | 8.076e-05 | 0.001546 |
244 | COVALENT CHROMATIN MODIFICATION | 75 | 345 | 8.111e-05 | 0.001547 |
245 | MESENCHYMAL CELL DIFFERENTIATION | 36 | 134 | 8.243e-05 | 0.001566 |
246 | MULTICELLULAR ORGANISM GROWTH | 24 | 76 | 8.311e-05 | 0.001566 |
247 | NUCLEAR IMPORT | 35 | 129 | 8.28e-05 | 0.001566 |
248 | CANONICAL WNT SIGNALING PATHWAY | 28 | 95 | 8.775e-05 | 0.001646 |
249 | RESPIRATORY SYSTEM DEVELOPMENT | 48 | 197 | 9.113e-05 | 0.001703 |
250 | SISTER CHROMATID SEGREGATION | 44 | 176 | 9.312e-05 | 0.001733 |
251 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 37 | 140 | 9.61e-05 | 0.001781 |
252 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 36 | 135 | 9.728e-05 | 0.001792 |
253 | BLOOD VESSEL MORPHOGENESIS | 78 | 364 | 9.743e-05 | 0.001792 |
254 | PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 163 | 873 | 9.994e-05 | 0.001831 |
255 | POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 13 | 30 | 0.0001013 | 0.001842 |
256 | RESPONSE TO EPIDERMAL GROWTH FACTOR | 13 | 30 | 0.0001013 | 0.001842 |
257 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 55 | 236 | 0.0001063 | 0.001925 |
258 | NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 28 | 96 | 0.0001073 | 0.001928 |
259 | CARDIOCYTE DIFFERENTIATION | 28 | 96 | 0.0001073 | 0.001928 |
260 | POSITIVE REGULATION OF SODIUM ION TRANSPORT | 14 | 34 | 0.0001079 | 0.001931 |
261 | KIDNEY MORPHOGENESIS | 25 | 82 | 0.000113 | 0.002015 |
262 | REGULATION OF ORGAN GROWTH | 23 | 73 | 0.0001205 | 0.002141 |
263 | CELL DEATH | 183 | 1001 | 0.0001245 | 0.002195 |
264 | CONNECTIVE TISSUE DEVELOPMENT | 47 | 194 | 0.0001241 | 0.002195 |
265 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 39 | 152 | 0.0001259 | 0.002203 |
266 | MITOTIC NUCLEAR DIVISION | 77 | 361 | 0.0001258 | 0.002203 |
267 | REGULATION OF MICROTUBULE BASED PROCESS | 56 | 243 | 0.0001271 | 0.002215 |
268 | REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 18 | 51 | 0.0001295 | 0.002248 |
269 | RESPONSE TO NITROGEN COMPOUND | 160 | 859 | 0.0001305 | 0.002257 |
270 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 51 | 216 | 0.0001316 | 0.002269 |
271 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 90 | 437 | 0.0001338 | 0.002297 |
272 | HINDBRAIN DEVELOPMENT | 36 | 137 | 0.0001344 | 0.0023 |
273 | POSITIVE REGULATION OF BINDING | 34 | 127 | 0.0001379 | 0.002351 |
274 | DEVELOPMENTAL INDUCTION | 12 | 27 | 0.0001395 | 0.00236 |
275 | HIPPO SIGNALING | 12 | 27 | 0.0001395 | 0.00236 |
276 | RNA STABILIZATION | 13 | 31 | 0.000152 | 0.002544 |
277 | CARDIAC MUSCLE CELL DIFFERENTIATION | 23 | 74 | 0.0001517 | 0.002544 |
278 | REGULATION OF NEURON PROJECTION REGENERATION | 10 | 20 | 0.0001517 | 0.002544 |
279 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 19 | 56 | 0.0001552 | 0.002589 |
280 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 75 | 352 | 0.0001583 | 0.002621 |
281 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 79 | 375 | 0.0001579 | 0.002621 |
282 | ENDOCRINE SYSTEM DEVELOPMENT | 33 | 123 | 0.0001643 | 0.00271 |
283 | REGULATION OF CYTOPLASMIC TRANSPORT | 97 | 481 | 0.0001683 | 0.002738 |
284 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 51 | 218 | 0.0001679 | 0.002738 |
285 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 51 | 218 | 0.0001679 | 0.002738 |
286 | REGULATION OF GTPASE ACTIVITY | 129 | 673 | 0.0001676 | 0.002738 |
287 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 62 | 279 | 0.0001708 | 0.002769 |
288 | REGULATION OF GENE SILENCING | 18 | 52 | 0.0001721 | 0.00278 |
289 | DNA TEMPLATED TRANSCRIPTION INITIATION | 48 | 202 | 0.0001738 | 0.002798 |
290 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 22 | 70 | 0.0001749 | 0.002807 |
291 | WOUND HEALING | 95 | 470 | 0.0001795 | 0.00287 |
292 | POSITIVE REGULATION OF MRNA 3 END PROCESSING | 9 | 17 | 0.0001877 | 0.002991 |
293 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 34 | 129 | 0.0001912 | 0.003036 |
294 | SOMATIC STEM CELL POPULATION MAINTENANCE | 21 | 66 | 0.0002009 | 0.00318 |
295 | ADULT LOCOMOTORY BEHAVIOR | 24 | 80 | 0.0002023 | 0.003184 |
296 | EYE DEVELOPMENT | 70 | 326 | 0.0002026 | 0.003184 |
297 | REGULATION OF MRNA 3 END PROCESSING | 12 | 28 | 0.0002128 | 0.00333 |
298 | POSITIVE REGULATION OF TRANSPORT | 171 | 936 | 0.0002133 | 0.00333 |
299 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 166 | 905 | 0.0002153 | 0.003345 |
300 | ENDOCRINE PANCREAS DEVELOPMENT | 15 | 40 | 0.0002157 | 0.003345 |
301 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 14 | 0.0002171 | 0.003345 |
302 | NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 8 | 14 | 0.0002171 | 0.003345 |
303 | REGENERATION | 40 | 161 | 0.0002179 | 0.003346 |
304 | PROTEIN UBIQUITINATION | 121 | 629 | 0.0002268 | 0.003471 |
305 | SOMITOGENESIS | 20 | 62 | 0.0002297 | 0.003505 |
306 | REGULATION OF GLUCOSE TRANSPORT | 28 | 100 | 0.0002306 | 0.003507 |
307 | NEPHRON DEVELOPMENT | 31 | 115 | 0.0002329 | 0.00353 |
308 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 149 | 801 | 0.0002338 | 0.003533 |
309 | RESPONSE TO MECHANICAL STIMULUS | 49 | 210 | 0.000238 | 0.003584 |
310 | REGULATION OF MITOTIC CELL CYCLE | 94 | 468 | 0.0002436 | 0.003656 |
311 | MUSCLE ORGAN DEVELOPMENT | 61 | 277 | 0.0002485 | 0.003718 |
312 | CARDIAC CELL DEVELOPMENT | 17 | 49 | 0.0002509 | 0.003741 |
313 | REGULATION OF CHROMATIN SILENCING | 10 | 21 | 0.0002529 | 0.00376 |
314 | NUCLEUS ORGANIZATION | 35 | 136 | 0.0002559 | 0.003793 |
315 | CHROMOSOME SEGREGATION | 60 | 272 | 0.0002652 | 0.003917 |
316 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 63 | 289 | 0.0002667 | 0.003927 |
317 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 100 | 505 | 0.0002688 | 0.003946 |
318 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 61 | 278 | 0.0002752 | 0.004014 |
319 | MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY | 16 | 45 | 0.0002746 | 0.004014 |
320 | SISTER CHROMATID COHESION | 30 | 111 | 0.0002773 | 0.004033 |
321 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 37 | 147 | 0.0002797 | 0.004054 |
322 | SENSORY ORGAN MORPHOGENESIS | 54 | 239 | 0.0002814 | 0.004066 |
323 | REGULATION OF BODY FLUID LEVELS | 100 | 506 | 0.0002893 | 0.004168 |
324 | SINGLE ORGANISM CELLULAR LOCALIZATION | 164 | 898 | 0.0002904 | 0.004171 |
325 | REGULATION OF BMP SIGNALING PATHWAY | 23 | 77 | 0.000292 | 0.004181 |
326 | CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS | 11 | 25 | 0.0002953 | 0.004215 |
327 | SINGLE ORGANISM CELL ADHESION | 92 | 459 | 0.0003035 | 0.004318 |
328 | MEMBRANE ORGANIZATION | 164 | 899 | 0.0003066 | 0.004349 |
329 | PALLIUM DEVELOPMENT | 38 | 153 | 0.0003111 | 0.004389 |
330 | REGULATION OF MUSCLE HYPERTROPHY | 14 | 37 | 0.0003122 | 0.004389 |
331 | PATTERN SPECIFICATION PROCESS | 85 | 418 | 0.0003122 | 0.004389 |
332 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 48 | 207 | 0.0003191 | 0.004472 |
333 | POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 13 | 33 | 0.0003204 | 0.004478 |
334 | PEPTIDYL SERINE MODIFICATION | 37 | 148 | 0.0003228 | 0.004484 |
335 | REGULATION OF ORGANELLE ASSEMBLY | 37 | 148 | 0.0003228 | 0.004484 |
336 | MAMMARY GLAND DEVELOPMENT | 31 | 117 | 0.0003245 | 0.004494 |
337 | REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 17 | 50 | 0.0003304 | 0.004538 |
338 | CELL ACTIVATION | 110 | 568 | 0.0003306 | 0.004538 |
339 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 17 | 50 | 0.0003304 | 0.004538 |
340 | CELLULAR RESPONSE TO OXYGEN LEVELS | 36 | 143 | 0.0003343 | 0.004574 |
341 | PANCREAS DEVELOPMENT | 22 | 73 | 0.0003413 | 0.004644 |
342 | HIPPOCAMPUS DEVELOPMENT | 22 | 73 | 0.0003413 | 0.004644 |
343 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 65 | 303 | 0.000344 | 0.004667 |
344 | RENAL TUBULE DEVELOPMENT | 23 | 78 | 0.0003593 | 0.004846 |
345 | SOMITE DEVELOPMENT | 23 | 78 | 0.0003593 | 0.004846 |
346 | MUSCLE CELL DEVELOPMENT | 33 | 128 | 0.0003653 | 0.004912 |
347 | POST GOLGI VESICLE MEDIATED TRANSPORT | 24 | 83 | 0.0003731 | 0.005003 |
348 | PLASMA MEMBRANE ORGANIZATION | 47 | 203 | 0.0003797 | 0.005063 |
349 | REGULATION OF CELL GROWTH | 80 | 391 | 0.0003787 | 0.005063 |
350 | NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 18 | 55 | 0.000381 | 0.005066 |
351 | NEGATIVE REGULATION OF CELL DEATH | 159 | 872 | 0.000385 | 0.005104 |
352 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 28 | 103 | 0.0003932 | 0.005194 |
353 | ANGIOGENESIS | 63 | 293 | 0.0003941 | 0.005194 |
354 | POSITIVE REGULATION OF DNA BINDING | 15 | 42 | 0.0004005 | 0.005249 |
355 | GENE SILENCING BY RNA | 35 | 139 | 0.0003996 | 0.005249 |
356 | UROGENITAL SYSTEM DEVELOPMENT | 64 | 299 | 0.0004049 | 0.005292 |
357 | REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 38 | 0.0004304 | 0.00561 |
358 | POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 11 | 26 | 0.0004467 | 0.005806 |
359 | REGULATION OF AUTOPHAGY | 55 | 249 | 0.0004505 | 0.005839 |
360 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 46 | 199 | 0.000452 | 0.005842 |
361 | REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 12 | 30 | 0.0004597 | 0.005926 |
362 | BONE DEVELOPMENT | 38 | 156 | 0.0004691 | 0.005974 |
363 | REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 7 | 12 | 0.0004679 | 0.005974 |
364 | ACTION POTENTIAL | 26 | 94 | 0.0004669 | 0.005974 |
365 | CELL FATE COMMITMENT | 51 | 227 | 0.0004699 | 0.005974 |
366 | POSITIVE REGULATION OF PROTEIN IMPORT | 28 | 104 | 0.0004664 | 0.005974 |
367 | EPITHELIAL TO MESENCHYMAL TRANSITION | 18 | 56 | 0.000488 | 0.00617 |
368 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 18 | 56 | 0.000488 | 0.00617 |
369 | RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 52 | 233 | 0.0004914 | 0.006197 |
370 | KIDNEY EPITHELIUM DEVELOPMENT | 32 | 125 | 0.0005083 | 0.006392 |
371 | POSITIVE REGULATION OF CELL DEATH | 115 | 605 | 0.0005118 | 0.006419 |
372 | ARTERY DEVELOPMENT | 22 | 75 | 0.0005178 | 0.006476 |
373 | VESICLE MEDIATED TRANSPORT | 216 | 1239 | 0.0005246 | 0.006544 |
374 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 57 | 262 | 0.0005353 | 0.006642 |
375 | REGULATION OF HORMONE SECRETION | 57 | 262 | 0.0005353 | 0.006642 |
376 | EAR DEVELOPMENT | 45 | 195 | 0.000538 | 0.006658 |
377 | REGULATION OF CHROMOSOME SEGREGATION | 24 | 85 | 0.0005478 | 0.006725 |
378 | REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 9 | 19 | 0.0005454 | 0.006725 |
379 | POSITIVE REGULATION OF CELL CYCLE ARREST | 24 | 85 | 0.0005478 | 0.006725 |
380 | METENCEPHALON DEVELOPMENT | 27 | 100 | 0.0005561 | 0.006744 |
381 | COGNITION | 55 | 251 | 0.0005529 | 0.006744 |
382 | REGULATION OF CELL MATRIX ADHESION | 25 | 90 | 0.0005549 | 0.006744 |
383 | ODONTOGENESIS | 28 | 105 | 0.0005513 | 0.006744 |
384 | ACTIVATION OF MAPKK ACTIVITY | 17 | 52 | 0.0005565 | 0.006744 |
385 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 37 | 152 | 0.0005606 | 0.006776 |
386 | HOMEOSTATIC PROCESS | 231 | 1337 | 0.0005666 | 0.00683 |
387 | REGULATION OF GENE EXPRESSION EPIGENETIC | 51 | 229 | 0.0005824 | 0.007003 |
388 | GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 14 | 39 | 0.0005847 | 0.007012 |
389 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 64 | 303 | 0.0005867 | 0.007018 |
390 | NEGATIVE REGULATION OF LOCOMOTION | 57 | 263 | 0.0005909 | 0.00705 |
391 | PLATELET ACTIVATION | 35 | 142 | 0.0006107 | 0.007268 |
392 | FEMALE SEX DIFFERENTIATION | 30 | 116 | 0.0006239 | 0.007406 |
393 | RHYTHMIC PROCESS | 63 | 298 | 0.0006289 | 0.007446 |
394 | REGULATION OF CELLULAR RESPONSE TO HEAT | 22 | 76 | 0.0006325 | 0.00747 |
395 | NUCLEAR ENVELOPE ORGANIZATION | 23 | 81 | 0.0006492 | 0.007647 |
396 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 234 | 1360 | 0.0006612 | 0.00777 |
397 | SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 26 | 96 | 0.000663 | 0.00777 |
398 | CELLULAR RESPONSE TO ACID CHEMICAL | 41 | 175 | 0.0006731 | 0.007869 |
399 | REGULATION OF JNK CASCADE | 38 | 159 | 0.0006948 | 0.008102 |
400 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 77 | 381 | 0.0007022 | 0.008169 |
401 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 20 | 67 | 0.0007144 | 0.008248 |
402 | MESONEPHRIC TUBULE MORPHOGENESIS | 17 | 53 | 0.0007125 | 0.008248 |
403 | RNA DESTABILIZATION | 8 | 16 | 0.0007137 | 0.008248 |
404 | ENDOTHELIAL CELL DIFFERENTIATION | 21 | 72 | 0.0007462 | 0.008573 |
405 | RESPONSE TO AMINO ACID | 29 | 112 | 0.0007462 | 0.008573 |
406 | REGULATION OF TRANSPORTER ACTIVITY | 45 | 198 | 0.0007586 | 0.008694 |
407 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 51 | 232 | 0.0007964 | 0.009105 |
408 | CARDIAC CHAMBER DEVELOPMENT | 35 | 144 | 0.0008013 | 0.009138 |
409 | NEGATIVE REGULATION OF CELL COMMUNICATION | 207 | 1192 | 0.0008354 | 0.009504 |
410 | REGULATION OF RNA STABILITY | 34 | 139 | 0.0008376 | 0.009506 |
411 | MYOBLAST FUSION | 9 | 20 | 0.0008675 | 0.009821 |
412 | INTRACELLULAR PROTEIN TRANSPORT | 142 | 781 | 0.0008708 | 0.009835 |
413 | MULTI ORGANISM TRANSPORT | 20 | 68 | 0.0008791 | 0.00988 |
414 | MULTI ORGANISM LOCALIZATION | 20 | 68 | 0.0008791 | 0.00988 |
415 | REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 51 | 233 | 0.0008818 | 0.009887 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ENZYME BINDING | 393 | 1737 | 1.721e-23 | 1.599e-20 |
2 | MACROMOLECULAR COMPLEX BINDING | 292 | 1399 | 9.008e-13 | 4.184e-10 |
3 | RNA BINDING | 323 | 1598 | 3.338e-12 | 1.034e-09 |
4 | POLY A RNA BINDING | 248 | 1170 | 1.087e-11 | 2.524e-09 |
5 | RIBONUCLEOTIDE BINDING | 362 | 1860 | 2.492e-11 | 4.629e-09 |
6 | ADENYL NUCLEOTIDE BINDING | 303 | 1514 | 5.562e-11 | 8.612e-09 |
7 | KINASE BINDING | 144 | 606 | 1.082e-10 | 1.437e-08 |
8 | CYTOSKELETAL PROTEIN BINDING | 181 | 819 | 2.644e-10 | 3.07e-08 |
9 | REGULATORY REGION NUCLEIC ACID BINDING | 179 | 818 | 7.53e-10 | 7.772e-08 |
10 | SEQUENCE SPECIFIC DNA BINDING | 215 | 1037 | 2.109e-09 | 1.959e-07 |
11 | CORE PROMOTER BINDING | 48 | 152 | 3.139e-08 | 2.481e-06 |
12 | PROTEIN KINASE ACTIVITY | 141 | 640 | 3.205e-08 | 2.481e-06 |
13 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 201 | 992 | 4.627e-08 | 3.307e-06 |
14 | KINASE ACTIVITY | 175 | 842 | 5.897e-08 | 3.913e-06 |
15 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 137 | 629 | 1.027e-07 | 6.015e-06 |
16 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 104 | 445 | 1.036e-07 | 6.015e-06 |
17 | RAN GTPASE BINDING | 17 | 31 | 1.297e-07 | 7.088e-06 |
18 | DOUBLE STRANDED DNA BINDING | 159 | 764 | 2.201e-07 | 1.136e-05 |
19 | CHROMATIN BINDING | 100 | 435 | 4.145e-07 | 2.027e-05 |
20 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 80 | 328 | 4.939e-07 | 2.294e-05 |
21 | PROTEIN COMPLEX BINDING | 185 | 935 | 8.614e-07 | 3.637e-05 |
22 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 126 | 588 | 8.293e-07 | 3.637e-05 |
23 | PROTEIN DOMAIN SPECIFIC BINDING | 132 | 624 | 9.514e-07 | 3.843e-05 |
24 | TRANSCRIPTION FACTOR BINDING | 114 | 524 | 1.272e-06 | 4.924e-05 |
25 | ZINC ION BINDING | 219 | 1155 | 2.183e-06 | 8.113e-05 |
26 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 85 | 371 | 3.439e-06 | 0.0001229 |
27 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 57 | 226 | 7.081e-06 | 0.0002437 |
28 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 73 | 315 | 1.078e-05 | 0.0003578 |
29 | CALMODULIN BINDING | 47 | 179 | 1.427e-05 | 0.0004573 |
30 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 63 | 264 | 1.618e-05 | 0.0005009 |
31 | ACTIN BINDING | 86 | 393 | 1.965e-05 | 0.0005888 |
32 | HEAT SHOCK PROTEIN BINDING | 28 | 89 | 2.385e-05 | 0.0006924 |
33 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 219 | 1199 | 2.883e-05 | 0.0008117 |
34 | STEROID HORMONE RECEPTOR BINDING | 26 | 81 | 3.119e-05 | 0.0008522 |
35 | NUCLEOCYTOPLASMIC TRANSPORTER ACTIVITY | 12 | 24 | 3.281e-05 | 0.0008707 |
36 | PROTEIN PHOSPHATASE BINDING | 34 | 120 | 4.016e-05 | 0.001033 |
37 | PROTEIN C TERMINUS BINDING | 47 | 186 | 4.115e-05 | 0.001033 |
38 | PROTEIN TRANSPORTER ACTIVITY | 29 | 99 | 7.484e-05 | 0.00183 |
39 | UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY | 88 | 420 | 8.446e-05 | 0.001941 |
40 | RIBONUCLEOPROTEIN COMPLEX BINDING | 28 | 95 | 8.775e-05 | 0.001941 |
41 | PDZ DOMAIN BINDING | 27 | 90 | 8.34e-05 | 0.001941 |
42 | GTPASE BINDING | 66 | 295 | 8.701e-05 | 0.001941 |
43 | HISTONE DEACETYLASE BINDING | 30 | 105 | 9.408e-05 | 0.002033 |
44 | HSP70 PROTEIN BINDING | 13 | 30 | 0.0001013 | 0.00214 |
45 | MAGNESIUM ION BINDING | 48 | 199 | 0.0001185 | 0.002447 |
46 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 42 | 168 | 0.0001327 | 0.00268 |
47 | TRANSITION METAL ION BINDING | 245 | 1400 | 0.0001762 | 0.003482 |
48 | PHOSPHATASE BINDING | 40 | 162 | 0.0002504 | 0.004846 |
49 | PROTEIN KINASE C BINDING | 17 | 50 | 0.0003304 | 0.006264 |
50 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 34 | 133 | 0.0003557 | 0.006608 |
51 | MRNA BINDING | 38 | 155 | 0.0004099 | 0.007467 |
52 | IDENTICAL PROTEIN BINDING | 212 | 1209 | 0.0004299 | 0.007681 |
53 | TRANSCRIPTION COREPRESSOR ACTIVITY | 50 | 221 | 0.0004479 | 0.007851 |
54 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 28 | 104 | 0.0004664 | 0.008024 |
55 | PROTEIN DIMERIZATION ACTIVITY | 202 | 1149 | 0.0005101 | 0.008313 |
56 | PHOSPHATIDYLINOSITOL BINDING | 46 | 200 | 0.0005078 | 0.008313 |
57 | MOLECULAR FUNCTION REGULATOR | 234 | 1353 | 0.000493 | 0.008313 |
58 | CHROMATIN DNA BINDING | 23 | 80 | 0.0005356 | 0.008579 |
59 | HORMONE RECEPTOR BINDING | 40 | 168 | 0.0005534 | 0.008714 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 265 | 1151 | 6.626e-17 | 3.87e-14 |
2 | CELL CELL JUNCTION | 102 | 383 | 8.047e-11 | 2.35e-08 |
3 | CELL PROJECTION | 336 | 1786 | 7.673e-09 | 1.494e-06 |
4 | ANCHORING JUNCTION | 115 | 489 | 1.535e-08 | 1.685e-06 |
5 | NUCLEAR PORE | 31 | 77 | 1.685e-08 | 1.685e-06 |
6 | MEMBRANE REGION | 227 | 1134 | 1.731e-08 | 1.685e-06 |
7 | NUCLEAR ENVELOPE | 101 | 416 | 2.107e-08 | 1.758e-06 |
8 | MICROTUBULE CYTOSKELETON | 215 | 1068 | 2.647e-08 | 1.932e-06 |
9 | CYTOSKELETON | 361 | 1967 | 3.422e-08 | 2.221e-06 |
10 | APICAL JUNCTION COMPLEX | 42 | 128 | 6.683e-08 | 3.903e-06 |
11 | PLASMA MEMBRANE REGION | 189 | 929 | 8.758e-08 | 4.65e-06 |
12 | CELL LEADING EDGE | 85 | 350 | 2.677e-07 | 1.303e-05 |
13 | NEURON PART | 241 | 1265 | 4.474e-07 | 2.01e-05 |
14 | CYTOSKELETAL PART | 268 | 1436 | 5.949e-07 | 2.481e-05 |
15 | GOLGI APPARATUS | 269 | 1445 | 7.024e-07 | 2.564e-05 |
16 | NUCLEOLUS | 171 | 848 | 6.602e-07 | 2.564e-05 |
17 | I BAND | 38 | 121 | 9.614e-07 | 3.303e-05 |
18 | SYNAPSE | 154 | 754 | 1.102e-06 | 3.575e-05 |
19 | TRANSFERASE COMPLEX | 144 | 703 | 2.08e-06 | 5.521e-05 |
20 | PCG PROTEIN COMPLEX | 19 | 43 | 1.846e-06 | 5.521e-05 |
21 | NUCLEOPLASM PART | 145 | 708 | 1.936e-06 | 5.521e-05 |
22 | NUCLEAR MEMBRANE | 69 | 280 | 1.988e-06 | 5.521e-05 |
23 | NEURON PROJECTION | 183 | 942 | 3.324e-06 | 8.44e-05 |
24 | CHROMOSOME | 172 | 880 | 4.52e-06 | 0.00011 |
25 | CELL SUBSTRATE JUNCTION | 88 | 398 | 1.041e-05 | 0.0002431 |
26 | ACTIN CYTOSKELETON | 96 | 444 | 1.117e-05 | 0.0002509 |
27 | VACUOLE | 218 | 1180 | 1.417e-05 | 0.0003012 |
28 | CATALYTIC COMPLEX | 195 | 1038 | 1.444e-05 | 0.0003012 |
29 | APICAL PART OF CELL | 79 | 361 | 4.192e-05 | 0.0008443 |
30 | PERINUCLEAR REGION OF CYTOPLASM | 127 | 642 | 4.518e-05 | 0.0008795 |
31 | EARLY ENDOSOME | 68 | 301 | 4.997e-05 | 0.0009413 |
32 | SYNAPSE PART | 120 | 610 | 9.261e-05 | 0.00166 |
33 | ENDOSOME | 150 | 793 | 9.951e-05 | 0.00166 |
34 | PLASMA MEMBRANE RAFT | 26 | 86 | 9.719e-05 | 0.00166 |
35 | VACUOLAR MEMBRANE | 116 | 587 | 9.921e-05 | 0.00166 |
36 | GOLGI APPARATUS PART | 166 | 893 | 0.0001089 | 0.001767 |
37 | CHROMATIN | 91 | 441 | 0.0001147 | 0.00181 |
38 | SOMATODENDRITIC COMPARTMENT | 126 | 650 | 0.0001215 | 0.001867 |
39 | SPINDLE | 64 | 289 | 0.0001504 | 0.002251 |
40 | MICROTUBULE | 84 | 405 | 0.0001725 | 0.002519 |
41 | NUCLEAR CHROMATIN | 64 | 291 | 0.0001847 | 0.00263 |
42 | APICAL PLASMA MEMBRANE | 64 | 292 | 0.0002044 | 0.002842 |
43 | TRANSCRIPTION FACTOR COMPLEX | 65 | 298 | 0.0002115 | 0.002873 |
44 | RUFFLE | 39 | 156 | 0.0002261 | 0.003001 |
45 | T TUBULE | 16 | 45 | 0.0002746 | 0.003564 |
46 | CELL CELL CONTACT ZONE | 20 | 64 | 0.0003691 | 0.004686 |
47 | MITOTIC SPINDLE | 18 | 55 | 0.000381 | 0.004735 |
48 | VACUOLAR PART | 130 | 694 | 0.0004269 | 0.005195 |
49 | GOLGI MEMBRANE | 131 | 703 | 0.0005056 | 0.005906 |
50 | CELL PROJECTION PART | 170 | 946 | 0.0005012 | 0.005906 |
51 | ENDOPLASMIC RETICULUM LUMEN | 46 | 201 | 0.0005697 | 0.006523 |
52 | CHROMOSOME CENTROMERIC REGION | 41 | 174 | 0.0005955 | 0.006688 |
53 | VESICLE MEMBRANE | 99 | 512 | 0.0006751 | 0.007438 |
54 | CLATHRIN COAT OF COATED PIT | 8 | 16 | 0.0007137 | 0.007719 |
55 | ENDOPLASMIC RETICULUM | 275 | 1631 | 0.0008137 | 0.00864 |
56 | EARLY ENDOSOME MEMBRANE | 29 | 113 | 0.0008701 | 0.009074 |
57 | CYTOPLASMIC STRESS GRANULE | 12 | 32 | 0.0009128 | 0.009352 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Focal_adhesion_hsa04510 | 59 | 199 | 1.223e-08 | 6.361e-07 | |
2 | Tight_junction_hsa04530 | 48 | 170 | 1.305e-06 | 2.283e-05 | |
3 | mTOR_signaling_pathway_hsa04150 | 44 | 151 | 1.406e-06 | 2.283e-05 | |
4 | MAPK_signaling_pathway_hsa04010 | 72 | 295 | 1.756e-06 | 2.283e-05 | |
5 | Cell_cycle_hsa04110 | 37 | 124 | 5.129e-06 | 5.334e-05 | |
6 | Rap1_signaling_pathway_hsa04015 | 53 | 206 | 7.936e-06 | 5.867e-05 | |
7 | Wnt_signaling_pathway_hsa04310 | 41 | 146 | 8.67e-06 | 5.867e-05 | |
8 | PI3K_Akt_signaling_pathway_hsa04151 | 80 | 352 | 9.027e-06 | 5.867e-05 | |
9 | Hippo_signaling_pathway_hsa04390 | 42 | 154 | 1.488e-05 | 8.599e-05 | |
10 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 38 | 139 | 3.505e-05 | 0.0001823 | |
11 | FoxO_signaling_pathway_hsa04068 | 36 | 132 | 5.871e-05 | 0.0002617 | |
12 | cGMP_PKG_signaling_pathway_hsa04022 | 42 | 163 | 6.373e-05 | 0.0002617 | |
13 | Ras_signaling_pathway_hsa04014 | 55 | 232 | 6.541e-05 | 0.0002617 | |
14 | cAMP_signaling_pathway_hsa04024 | 48 | 198 | 0.000104 | 0.0003863 | |
15 | Apelin_signaling_pathway_hsa04371 | 36 | 137 | 0.0001344 | 0.0004661 | |
16 | ErbB_signaling_pathway_hsa04012 | 25 | 85 | 0.0002126 | 0.0006909 | |
17 | Adherens_junction_hsa04520 | 22 | 72 | 0.0002748 | 0.0008405 | |
18 | Calcium_signaling_pathway_hsa04020 | 43 | 182 | 0.0004186 | 0.001209 | |
19 | Cellular_senescence_hsa04218 | 38 | 160 | 0.0007889 | 0.002159 | |
20 | Phospholipase_D_signaling_pathway_hsa04072 | 35 | 146 | 0.001042 | 0.00271 | |
21 | Regulation_of_actin_cytoskeleton_hsa04810 | 45 | 208 | 0.002177 | 0.005198 | |
22 | Gap_junction_hsa04540 | 23 | 88 | 0.002199 | 0.005198 | |
23 | AMPK_signaling_pathway_hsa04152 | 29 | 121 | 0.002688 | 0.006074 | |
24 | HIF_1_signaling_pathway_hsa04066 | 25 | 100 | 0.002804 | 0.006074 | |
25 | Cell_adhesion_molecules_.CAMs._hsa04514 | 33 | 145 | 0.003488 | 0.007256 | |
26 | Hippo_signaling_pathway_multiple_species_hsa04392 | 10 | 29 | 0.004896 | 0.009792 | |
27 | VEGF_signaling_pathway_hsa04370 | 16 | 59 | 0.006675 | 0.01286 | |
28 | Hedgehog_signaling_pathway_hsa04340 | 13 | 47 | 0.0116 | 0.02154 | |
29 | Sphingolipid_signaling_pathway_hsa04071 | 26 | 118 | 0.01339 | 0.02401 | |
30 | Oocyte_meiosis_hsa04114 | 27 | 124 | 0.01387 | 0.02405 | |
31 | Endocytosis_hsa04144 | 46 | 244 | 0.02494 | 0.04184 | |
32 | TNF_signaling_pathway_hsa04668 | 23 | 108 | 0.02788 | 0.0453 | |
33 | ECM_receptor_interaction_hsa04512 | 18 | 82 | 0.03653 | 0.05757 | |
34 | Phosphatidylinositol_signaling_system_hsa04070 | 20 | 99 | 0.06186 | 0.09461 | |
35 | NF_kappa_B_signaling_pathway_hsa04064 | 19 | 95 | 0.07326 | 0.1088 | |
36 | TGF_beta_signaling_pathway_hsa04350 | 17 | 84 | 0.07933 | 0.1146 | |
37 | Autophagy_animal_hsa04140 | 24 | 128 | 0.08975 | 0.1261 | |
38 | p53_signaling_pathway_hsa04115 | 14 | 68 | 0.09334 | 0.1277 | |
39 | Ferroptosis_hsa04216 | 9 | 40 | 0.1036 | 0.1382 | |
40 | Lysosome_hsa04142 | 22 | 123 | 0.1459 | 0.1897 | |
41 | Apoptosis_hsa04210 | 24 | 138 | 0.1662 | 0.2108 | |
42 | Cytokine_cytokine_receptor_interaction_hsa04060 | 43 | 270 | 0.2253 | 0.279 | |
43 | Notch_signaling_pathway_hsa04330 | 9 | 48 | 0.233 | 0.2818 | |
44 | Apoptosis_multiple_species_hsa04215 | 6 | 33 | 0.3225 | 0.3812 | |
45 | Jak_STAT_signaling_pathway_hsa04630 | 25 | 162 | 0.3547 | 0.4099 | |
46 | ABC_transporters_hsa02010 | 6 | 45 | 0.6288 | 0.7109 | |
47 | Autophagy_other_hsa04136 | 4 | 32 | 0.6833 | 0.756 | |
48 | Mitophagy_animal_hsa04137 | 8 | 65 | 0.7195 | 0.7795 | |
49 | Peroxisome_hsa04146 | 10 | 83 | 0.7562 | 0.7869 | |
50 | Phagosome_hsa04145 | 19 | 152 | 0.7566 | 0.7869 | |
51 | Necroptosis_hsa04217 | 19 | 164 | 0.8578 | 0.8746 | |
52 | Neuroactive_ligand_receptor_interaction_hsa04080 | 33 | 278 | 0.8857 | 0.8857 |